The heart and cardiovascular manifestations in rheumatoid arthritis (Q36596365)

15 August 2017

1 reference

title

The heart and cardiovascular manifestations in rheumatoid arthritis (English)

1 reference

15 August 2017

1 reference

Voskuyl AE

1

1 reference

15 August 2017

publication date

1 October 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

45 Suppl 4

1 reference

15 August 2017

page(s)

iv4-7

1 reference

The mortality of rheumatoid vasculitis compared with rheumatoid arthritis.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

Extraarticular manifestations of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

The extra-articular features of rheumatoid arthritis. A systematic analysis of 127 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

Etiologic diagnosis of 204 pericardial effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

Contrast-enhanced MR imaging of the heart: overview of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

The prevalence of subclinical amyloidosis in Polish patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

Coronary arteritis complicating rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

Rheumatoid arthritis: extra-articular manifestations. II

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

Heart rate variability in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

Echocardiographic findings and 24-h electrocardiographic Holter monitoring in patients with nodular and non-nodular rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

Incidence of noncardiac vascular disease in rheumatoid arthritis and relationship to extraarticular disease manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

Raised erythrocyte sedimentation rate signals heart failure in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

Left ventricular systolic dysfunction in rheumatoid disease: an unrecognized burden?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

Effect of glucocorticoids on the arteries in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

Anti-tumor necrosis factor alpha therapy and heart failure: what have we learned and where do we go from here?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

TNF-alpha, rheumatoid arthritis, and heart failure: a rheumatological dilemma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

Problem of the atherothrombotic potential of non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

Cardiovascular risk and rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

Making an impact on mortality in rheumatoid arthritis: targeting cardiovascular comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

The risk of congestive heart failure in rheumatoid arthritis: A population-based study over 46 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEL313

10.1093/RHEUMATOLOGY/KEL313

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference